Serial secretoneurin measurement and risk of ventricular arrhythmias and death in patients with left ventricular systolic dysfunction
In stable ambulatory patients with reduced LV systolic function and a primary prevention indication for ICD, secretoneurin concentration was associated with the risk of death but not ventricular tachyarrhythmia.
Authors
- Helge Rørvik Røsjø (ORCID: https://orcid.org/0000-0003-2114-3134)
- Glenn M. Polin
- Aimee Elise Hiltbold
- Daniel P. Morin (ORCID: https://orcid.org/0000-0002-9637-9507)
- Torbjørn Omland (ORCID: https://orcid.org/0000-0002-6452-0369)
- Paul A. Rogers
- Torbjørn Fosen Wisløff (ORCID: https://orcid.org/0000-0002-7539-082X)
- Michael L. Bernard (ORCID: https://orcid.org/0000-0002-8554-2241)
- Sammy Khatib
Institutions
- University of Oslo (NO)
- Ochsner Medical Center (US)
- Akershus University Hospital (NO)
Publication Details
- Journal
- Clinical Biochemistry
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1016/j.clinbiochem.2024.110868
- Citations
- 1
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Boston Scientific Corporation